The ALT and AST levels in the LNP-siTGFβRI-treated groups showed a decreasing trend, but were not statistically significant compared to the PBS-treated group ( Fig 5F ).
← all excerpts
Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni.
1
—
—